| Absorption |
| Blood-Brain Barrier | BBB- | 0.9767 |
| Human Intestinal Absorption | HIA+ | 0.9824 |
| Caco-2 Permeability | Caco2+ | 0.8335 |
| P-glycoprotein Substrate | Substrate | 0.8147 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8774 |
| Non-inhibitor | 0.8229 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8090 |
| Distribution |
| Subcellular localization | Lysosome | 0.6023 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8430 |
| CYP450 2D6 Substrate | Non-substrate | 0.8884 |
| CYP450 3A4 Substrate | Non-substrate | 0.6356 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8199 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8246 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9001 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8252 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8325 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6425 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9433 |
| Non-inhibitor | 0.7847 |
| AMES Toxicity | AMES toxic | 0.6221 |
| Carcinogens | Non-carcinogens | 0.8088 |
| Fish Toxicity | High FHMT | 0.9931 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9316 |
| Honey Bee Toxicity | Low HBT | 0.8932 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.7770 |
| Carcinogenicity (Three-class) | Non-required | 0.5540 |